Understanding Rheumatoid Arthritis: Symptoms, Diagnosis, and Modern Treatment

Rheumatoid arthritis (RA) is one of the most common autoimmune conditions I see in my rheumatology practice. Affecting approximately 400,000 people in the UK, it is a condition that benefits enormously from early specialist assessment and treatment.

What Is Rheumatoid Arthritis?

RA is a chronic autoimmune condition where the immune system mistakenly attacks the synovium — the lining of the joints. This causes inflammation, leading to pain, swelling, and stiffness. Over time, untreated inflammation can damage cartilage and bone within the joint, leading to permanent deformity and disability.

Recognising the Symptoms

The key symptoms to watch for include persistent joint pain and swelling, particularly in the small joints of the hands and feet. Morning stiffness lasting more than 30 minutes is a hallmark feature — this distinguishes RA from osteoarthritis, where stiffness typically improves within minutes. Fatigue is another common symptom that significantly affects quality of life.

RA typically affects joints symmetrically — if one hand is affected, the other usually is too. Common early sites include the knuckles (MCP joints), the middle finger joints (PIP joints), and the balls of the feet (MTP joints).

Why Early Diagnosis Matters

Research consistently shows that treating RA within the first 12 weeks of symptom onset — the so-called 'window of opportunity' — leads to significantly better long-term outcomes. Early treatment can prevent the irreversible joint damage that was once considered inevitable in RA.

This is why I always encourage anyone with persistent joint swelling and morning stiffness to seek specialist assessment promptly, rather than waiting to see if symptoms improve on their own.

How Is RA Diagnosed?

Diagnosis involves a combination of clinical examination, blood tests, and imaging. Key blood tests include rheumatoid factor (RF) and anti-CCP antibodies, which are present in approximately 70-80% of RA patients. Inflammatory markers (CRP and ESR) help assess disease activity. Ultrasound and MRI can detect joint inflammation and early damage that may not be visible on X-ray.

It is important to note that approximately 20% of RA patients are 'seronegative' — meaning their blood tests for RF and anti-CCP are negative. RA can still be diagnosed based on clinical findings and imaging.

Modern Treatment Approaches

The treatment landscape for RA has been transformed over the past two decades. The goal of treatment is now remission or low disease activity, not merely symptom control.

**First-line treatment** typically involves methotrexate, a disease-modifying antirheumatic drug (DMARD) that is highly effective and has an excellent long-term safety record. It is usually taken as a weekly tablet or injection.

**Biologic therapies** are available for patients who do not respond adequately to conventional DMARDs. These targeted treatments block specific inflammatory molecules and include anti-TNF agents, IL-6 inhibitors, and others. As a Principal Investigator in multiple rheumatological trials, I have extensive experience with these therapies and access to the latest treatment options.

**JAK inhibitors** are a newer class of targeted treatment available as tablets, offering an alternative to injectable biologics.

Living Well With RA

Beyond medication, several factors contribute to managing RA effectively. Regular exercise helps maintain joint flexibility and muscle strength. A balanced diet supports overall health. Stopping smoking is particularly important, as smoking is both a risk factor for RA and reduces the effectiveness of treatment.

When to Seek Specialist Help

If you are experiencing persistent joint pain and swelling, morning stiffness lasting more than 30 minutes, or have a family history of RA and are developing symptoms, I would encourage you to seek specialist assessment. Self-referral is accepted at my private clinic at The Beaumont Hospital, Bolton — no GP referral is needed. Call 01204 404404 to book.

*Last medically reviewed by Dr Leena Das, March 2026*